These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33365061)

  • 1. Interaction network of immune-associated genes affecting the prognosis of patients with glioblastoma.
    Hou X; Chen J; Zhang Q; Fan Y; Xiang C; Zhou G; Cao F; Yao S
    Exp Ther Med; 2021 Jan; 21(1):61. PubMed ID: 33365061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
    Yang J; Wang L; Xu Z; Wu L; Liu B; Wang J; Tian D; Xiong X; Chen Q
    Front Genet; 2020; 11():253. PubMed ID: 32296458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 63 signature genes prediction system is effective for glioblastoma prognosis.
    Zhang Y; Xu J; Zhu X
    Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of high-throughput data to validate potential novel biomarkers and small molecule drugs for glioblastoma multiforme.
    Qi F; Li Q; Lu X; Chen Z
    J Int Med Res; 2020 Jul; 48(7):300060520924541. PubMed ID: 32634050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of Potential Glioblastoma Multiforme-Related miRNA-mRNA Regulatory Network.
    Lou W; Ding B; Xu L; Fan W
    Front Mol Neurosci; 2019; 12():66. PubMed ID: 30971889
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of alternative splicing signatures in the prognosis of glioblastoma.
    Xie ZC; Wu HY; Dang YW; Chen G
    Cancer Med; 2019 Dec; 8(18):7623-7636. PubMed ID: 31674730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma.
    Yin W; Tang G; Zhou Q; Cao Y; Li H; Fu X; Wu Z; Jiang X
    Front Genet; 2019; 10():419. PubMed ID: 31130992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis.
    Yang L; Zeng W; Sun H; Huang F; Yang C; Cai X; Lu Y; Zeng J; Yang K
    World Neurosurg; 2020 Jun; 138():e492-e514. PubMed ID: 32147549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of aberrantly methylated differentially expressed genes in glioblastoma multiforme and their association with patient survival.
    Zhang M; Lv X; Jiang Y; Li G; Qiao Q
    Exp Ther Med; 2019 Sep; 18(3):2140-2152. PubMed ID: 31452706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Crucial Candidate Genes and Pathways in Glioblastoma Multiform by Bioinformatics Analysis.
    Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
    Biomolecules; 2019 May; 9(5):. PubMed ID: 31137733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis.
    Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J
    Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential biomarkers and candidate small molecule drugs in glioblastoma.
    Lu WC; Xie H; Yuan C; Li JJ; Li ZY; Wu AH
    Cancer Cell Int; 2020; 20():419. PubMed ID: 32874133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key candidate genes and pathways in glioblastoma by integrated bioinformatical analysis.
    Li L; Liu X; Ma X; Deng X; Ji T; Hu P; Wan R; Qiu H; Cui D; Gao L
    Exp Ther Med; 2019 Nov; 18(5):3439-3449. PubMed ID: 31602219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of glioblastoma-specific prognostic biomarkers via an integrative analysis of DNA methylation and gene expression.
    Mao YK; Liu ZB; Cai L
    Oncol Lett; 2020 Aug; 20(2):1619-1628. PubMed ID: 32724403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method.
    Wang H; Liu D; Yang J
    Neoplasma; 2019 May; 66(3):459-469. PubMed ID: 30784292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of differentially expressed genes associated with human glioblastoma and functional analysis using a DNA microarray.
    Wang L; Wei B; Hu G; Wang L; Bi M; Sun Z; Jin Y
    Mol Med Rep; 2015 Aug; 12(2):1991-6. PubMed ID: 25901754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of microenvironment-related genes associated with radioresistance in glioblastoma.
    Liu Y; Zhao Y; Fang J; Fang J; Yuan X
    Transl Cancer Res; 2020 Dec; 9(12):7495-7504. PubMed ID: 35117350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Analyses of Prognostic-Related Immune Genes and Immune Infiltrates for Glioblastoma.
    Liang P; Chai Y; Zhao H; Wang G
    Diagnostics (Basel); 2020 Mar; 10(3):. PubMed ID: 32214002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening seven hub genes associated with prognosis and immune infiltration in glioblastoma.
    Zhang Y; Fan H; Zou C; Wei F; Sun J; Shang Y; Chen L; Wang X; Hu B
    Front Genet; 2022; 13():924802. PubMed ID: 36035134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.